Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation.

Saved in:
Bibliographic Details
Title: Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation.
Authors: Givi, Taraneh1 (AUTHOR), Mohajerani, Fatemeh1 (AUTHOR), Tehrankhah, Zahra Moazezi1 (AUTHOR), Karimi Taheri, Mohammadjavad1 (AUTHOR), Amirahmadi, Maryam2 (AUTHOR), Babashah, Sadegh1 (AUTHOR), Sadeghizadeh, Majid1 (AUTHOR) sadeghma@modares.ac.ir
Source: PLoS ONE. 12/5/2025, Vol. 20 Issue 12, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0335165